These side effects are mild
This work not only deepens scientific insight into ipamorelin's mechanism but also supports its potential as a well-tolerated therapeutic option for conditions requiring growth hormone modulation, paving the way for future clinical applications
Oral glutathione was long dismissed as pointless the argument was that the peptide would be digested in the stomach and never reach systemic circulation
This is in line with the fact that, although some studies have shown the presence of the GLP-1R in other parts of the heart ( Apart from the chronotropic effects, direct effects of GLP-1 specifically on the heart have not been comprehensively documented, although evidence exists to suggest that GLP-1 RAs may improve cardiac output as well as cardiomyocyte survival ( It should be noted that one of the two major DPP-IV-generated truncated forms of GLP-1 (GLP-1 [9-36amide]) has been shown to have direct beneficial cardiac effects in mice, which is representative of the hypothesis that a GLP-1R-associated response can be elicited also by these metabolites and thus not only via the classic incretin pathway ( Future perspectives In summary, the cardiovascular safety of all currently marketed GLP-1 RAs has been thoroughly established in large CVOTs ( As noted by others ( Of note, the finding of a markedly greater benefit on HF of efpeglenatide amongst trial participants using SGLT2 inhibitors at enrolment in the AMPLITUDE-O CVOT highlights another important point ( Another drug class widely used to treat type 2 diabetes is inhibitors of the enzyme dipeptidyl peptidase-4 (DPP4), which mediates enzymatic breakdown of GLP-1
Clinical Evidence: Why GLP-1 Works for Weight Loss and Diabetes The landmark SUSTAIN and SELECT trials demonstrated that GLP-1 agonists reduce body weight by 5 to 22 percent depending on the medication, dose, and baseline characteristics
Scientists are still working to understand the relationship between GLP-1s and Alzheimers
